Why do some vaccines (polio, measles) prevent diseases, while others (COVID-19, flu) only reduce their severity? – Medical Xpress
                            November 3, 2023
                                    This article has been reviewed according to        ScienceX's editorial process and policies. Editors have highlighted the following        attributes while ensuring the content's credibility:      
          fact-checked        
          trusted source        
          proofread        
         close      
    When the first vaccines for COVID-19 rolled out in December    2020, some people hoped they would be a silver bullet against    the novel virus the way that polio and smallpox shots are    nearly 100% effective against those diseases.  
    Instead, the updated COVID vaccine is being compared to the flu    vaccine in the sense that its goal is to prevent severe    disease, hospitalization and death rather than to eliminate    infection entirely.  
    That doesn't mean the COVID and flu vaccines are failures,    health experts at Northeastern say.  
    Mansoor Amiji, university distinguished professor of    pharmaceutical sciences and chemical engineering, and Neil    Maniar, professor of the practice in public health, say    vaccines differ according to whether the viruses they've been    designed to quell are mutating or stable.  
    The measles and polio viruses are stable and don't mutate over    time, Amiji says. The same is true for the virus for smallpox,    which has been eradicated globally and only exists in the lab.  
    Making a vaccine with an antigen from a stable virus means a    vaccinated person's immune system is primed to recognize and    destroy the virus every time it appears, Amiji says.  
    "If you start to see an outbreak of polio, in any part of the    world, these vaccines are still incredibly effective. If the    virus crops up, it won't evade the immune system or evade the    vaccine's response," he says.  
    Such is not the case with influenza, the virus that causes flu,    and SARS-CoV-2, the virus that causes COVID-19.  
    COVID-19 has gone through an alphabet soup of strains, from the    alpha to beta, delta, omicron, Pirola and Erisand is still    evolving.  
    "Even though we have so many people either having natural    infection or who have been vaccinated, these viruses continue    to mutate," Amiji says.  
    "We're making vaccines that are looking for the spike proteins in the virus and are    basically teaching our immune cells to look for the spike protein. But    if the spike protein is mutating, then the vaccine efficacy    starts to wane," he says.  
    Influenza mutates even faster, which is why there are new flu    vaccine formulas every year and why 50% is considered a good    efficacy rate, he says.  
    The combinations of antigenic proteins on the influenza    surface, known as hemagglutinin and neuraminidasethe H and N    in virus nomenclaturevary year to year and even within the    flu season, Amiji says.  
    The flu vaccine is "made up of a cocktail of these peptides,"    he says. "It's really a guessing game. There is no way of    knowing which strain will be prevalent and which vaccines will    work," he says.  
    That rate is making the flu vaccine a harder sell among the    public.  
    The     Centers for Disease Control and Prevention says during a    year with a good match, vaccination reduces the risk of flu    illness by between 40% and 60% among the overall population.  
    Consumer research shows "that many people believe flu    vaccination doesn't work because of first- or second-hand    experience where vaccination may not have prevented illness,"    the CDC says.  
    Concerned about drops in flu vaccination among high-risk groups such    as pregnant women and children    during the COVID-19 pandemic, the CDC this fall came up with a    new campaignone that spotlights how the flu vaccine can reduce    not only the risk of influenza but of potentially serious    outcomes.  
    Called "Wild to Mild," the campaign pairs images of powerful    and dangerous animals with innocuous counterpartsa raging bear    with a teddy bear or a lion with a kitten, for instance.  
    "It's definitely a change in messaging," Maniar says.  
    "It's a clarification in what is being messaged," he says.    "There has been sort of this prevailing idea that, "If I get    the vaccine, I'm not going to get the flu." And we know that's    not the case."  
    "There's a lot of empirical evidence to show what the vaccine    really does is it reduces severity. It reduces the likelihood    that someone is going to be hospitalized or even die from    getting the flu," Maniar says.  
    The same is true with vaccination for COVID-19, he says.  
    "There are some individuals who after getting vaccinated will    not get the flu or get COVID, because their immune systems have    a more robust protection against the virus," Maniar says.  
    "But that's not the case for everyone. I think that's where    managing expectations comes into play," he says.  
    The updated COVID vaccineno longer called a booster by the    FDAtargets the XBB.1.5 omicron strain prevalent this spring.    Pfizer says the monovalent vaccine also addresses currently    circulating offshoots of omicron, known as eris or EG.5,    andpirola, BA.2.86.  
    "Vaccination remains right now our best strategy to not just    ideally prevent but to have a benign type of infection, just    basically a few chills and a sore throat," Amiji says.  
    "It would be great if you don't get infected. But even if you    do get the infection it will be very mild, and you won't be    hospitalized."  
    The flu virus undergoes both antigenic shifts and drifts, Amiji    says.  
    The former is when hemagglutinin and neuraminidase undergo such    huge changes the influenza vaccine is not effective at all.    Drift is when slight modification occurs, he says.  
    There are glimmers of hope that both flu and COVID vaccines    will become more effective in the future, Amiji says.  
    Using AI in pharmaceutical technology has led to preclinical    studies showing the effectiveness of a universal mRNA flu vaccine that covers more than dozen flu    strains in a season, he says.  
    "The same concept is being applied to a universal COVID    vaccine," Amiji says.  
    "They're not in the clinic yet," he says, but adds he wouldn't    be surprised if they were on the market by next fall.  
    In the meantime, Amiji says he plans to get the updated COVID    vaccine and a flu shot this weekend.  
    "I would absolutely recommend that people get their flu and    COVID vaccines as soon as possible," he says.  
    "As we get toward the winter season, and people start    congregating with Thanksgiving holidays and Christmas holidays,    the propensity for infection just increases."       
Read the original here:
Why do some vaccines (polio, measles) prevent diseases, while others (COVID-19, flu) only reduce their severity? - Medical Xpress